Items where Author is "Pestalozzi, Bernhard C."

Yes

Pagani, Olivia and Klingbiel, Dirk and Ruhstaller, Thomas and Nole, Franco and Eppenberger-Castori, Serenella and Oehlschlegel, Christian and Bernhard, Jürg and Brauchli, Peter and Hess, Dagmar and Mamot, Christoph and Munzone, Elisabetta and Pestalozzi, Bernhard C. and Rabaglio, Manuela and Aebi, Stefan and Ribi, Karin and Rochlitz, Christoph and Rothgiesser, Karin and Thürlimann, Beat and von Moos, Roger and Zaman, Khalil and Goldhirsch, Aron and Swiss Group for Clinical Cancer, Research. (2017) Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99. Annals of Oncology, 28 (2). pp. 305-312.

Dedes, Konstantin J. and Matter-Walstra, Klazien and Schwenkglenks, Matthias and Pestalozzi, Bernhard C. and Fink, Daniel and Brauchli, Peter and Szucs, Thomas D.. (2009) Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer : an economic evaluation. EJC : European journal of cancer, Vol. 45, H. 8. pp. 1397-1406.

Klaeser, Bernd and Nitzsche, Egbert and Schuller, Jan C. and Köberle, Dieter and Widmer, Lucas and Balmer-Majno, Sabine and Hany, Thomas and Cescato-Wenger, Corinne and Brauchli, Peter and Zünd, Michael and Pestalozzi, Bernhard C. and Caspar, Clemens and Albrecht, Susanne and von Moos, Roger and Ruhstaller, Thomas. (2009) Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer : results of a prospective multi-center trial (SAKK 75/02). Onkologie, 32 (12). pp. 724-730.

Pestalozzi, Bernhard C. and Zahrieh, David and Mallon, Elizabeth and Gusterson, Barry A. and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Lindtner, Jurij and Snyder, Raymond and Thürlimann, Beat and Murray, Elizabeth and Viale, Giuseppe and Castiglione-Gertsch, Monica and Coates, Alan S. and Goldhirsch, Aron. (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast : combined results of 15 International Breast Cancer Study Group clinical trials. Journal of clinical oncology, Vol. 26. pp. 3006-3014.